Pfizer gets early US termination for Metsera buy
Pfizer has received antitrust clearance from US authorities for its $4.9 billion deal for obesity startup company Metsera. In a positive sign for Pfizer, the company’s offer is understood to have...To view the full article, register now.
Already a subscriber? Click here to view full article